Submissions for variant NM_020661.4(AICDA):c.48A>G (p.Lys16=)

gnomAD frequency: 0.00117  dbSNP: rs186739900

Total submissions: 5

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Eurofins Ntd Llc (ga)	RCV000321345	SCV000334100	uncertain significance	not provided	2018-01-22	criteria provided, single submitter	clinical testing
Illumina Laboratory Services, Illumina	RCV001085627	SCV000381284	uncertain significance	Hyper-IgM syndrome type 2	2018-01-12	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Invitae	RCV001085627	SCV000760954	likely benign	Hyper-IgM syndrome type 2	2024-01-18	criteria provided, single submitter	clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV001201224	SCV001372316	benign	not specified	2020-06-18	criteria provided, single submitter	clinical testing
CeGaT Center for Human Genetics Tuebingen	RCV000321345	SCV001746124	likely benign	not provided	2021-04-01	criteria provided, single submitter	clinical testing